HTGF backs Kumovis
High-Tech Gründerfonds has invested in a seed round for medical technology-focused 3D printing company Kumovis.
The value of the financing was not disclosed but was said to be in the seven-figure range. HTGF’s latest investment fund closed on €316.5m in May this year and generally makes initial investments between €1-3m.
An unnamed family office also took part in the financing.
The fresh capital will be used to prepare for the market launch of Kumovis’ printers.
Company
Kumovis was founded in 2017 as a spin-out from the Technical University of Munich. The company develops 3D printers for the manufacturing of plastic implants from PEEK and PPSU polymers.
People
High-Tech Gründerfonds – Marie Asano (investment manager).
Kumovis – Alexander Henhammer (co-founder).
More on Early-stage
Sidekick spinoffs: Insurtech scale-ups attract PE interest
Investment set to break EUR 1.1bn mark this year as sponsors seek for rising stars
World Fund leads EUR 128m raise for quantum computing group IQM
Series-A2 for Finnish startup focused on combating the climate crisis also backed by the EIB
Gorillas raises circa USD 1bn in Delivery Hero-led Series C
New funding comes just seven months after a Series B, with the company doubling in value
French mega-rounds shoot up in 2021
France has already seen as many rounds of EUR 100m and above than in 2019 and 2020 combined, Unquote Data shows
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater